Streetbeat News

Analyst Ratings

ETON

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a 'Buy' rating on Eton Pharmaceuticals (NASDAQ:ETON) but lowers the price target from $10 to $9.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:11 am

ENSC

HC Wainwright & Co. analyst Raghuram Selvaraju has initiated coverage on Ensysce Biosciences (NASDAQ:ENSC) with a Buy rating and a price target of $9.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:10 am

BTAI

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a 'Buy' rating on BioXcel Therapeutics but lowers the price target from $66 to $60.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:09 am

BLCO

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Bausch & Lomb (NYSE:BLCO) and maintained a price target of $22.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:08 am

MITK

HC Wainwright & Co. analyst Scott Buck has reiterated a 'Buy' rating on Mitek Systems (NASDAQ:MITK) and maintained a $19 price target.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:04 am

FEMY

Chardan Capital analyst Keay Nakae has reiterated a 'Buy' rating on Femasys (NASDAQ:FEMY) and maintained a price target of $10.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 10:03 am

AMZN

DBS Bank analyst Sachin Mittal has initiated coverage on Amazon.com (NASDAQ:AMZN) with a Buy rating and a price target of $150.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 9:59 am

AMC

Citigroup analyst Jason Bazinet has reiterated a 'Sell' rating on AMC Enter Hldgs (NYSE:AMC) and maintained a price target of $1.65.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:57 am

AAPL

CCL

NVDA

The S&P 500 and Nasdaq recorded gains on Friday, with Apple Inc. reaching a $3 trillion market capitalization for the first time. The Nasdaq had its strongest first-half performance in 40 years, while the S&P 500 jumped 8.3% for the quarter. Carnival Corporation shares gained 9.7% after Jefferies upgraded the stock from Hold to Buy and raised the price target from $9 to $25. The CBOE Volatility Index rose 0.4% to close at 13.59 on Friday.

Portfolio Pulse from Lisa Levin

July 03, 2023 | 9:54 am

PAYX

Barclays analyst Matt Ramsay has maintained an 'Underweight' rating on Paychex (NASDAQ:PAYX) and lowered the price target from $109 to $106.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:54 am